Prostaglandin inhibitors and gastric factors in migraine.
D001241:Aspirin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004878:Ergotamine / Q000627:therapeutic use*; D005746:Gastric Emptying / Q000187:drug effects*; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D011448:Prostaglandin Antagonists / Q000627:therapeutic use*; D062367:ortho-Aminobenzoates / Q000627:therapeutic use*
D011448:Prostaglandin Antagonists; D062367:ortho-Aminobenzoates; C009500:tolfenamic acid; D004878:Ergotamine; D001241:Aspirin